Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Treatment simplification of complex insulin regimens in T2D

Treatment simplification of complex insulin regimens in T2D

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Gaucher

Gaucher

Challenges associated with commonly-used insulin advancement options

Challenges associated with commonly-used insulin advancement options

Better care for Fabry

Better care for Fabry

Every Moment Matters on the Fabry Journey

EVOLUTION: RWE from Saudi Arabia

EVOLUTION: RWE from Saudi Arabia

How To Diagnose LSDs?

How To Diagnose LSDs?

Learn more about early diagnosis of lysosomal storage disorders: Fabry disease, Pompe Disease, Gaucher disease, Acid Sphingomyelinase Deficiency (ASMD, also known as Niemann-Pick Type A/B), mucopolysaccharidoses (MPSs).

Inside Diabetes: ATTD Edition | Type 1 Diabetes

Inside Diabetes: ATTD Edition | Type 1 Diabetes